Correlation Between Bionoid Pharma and Benchmark Botanics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bionoid Pharma and Benchmark Botanics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bionoid Pharma and Benchmark Botanics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bionoid Pharma and Benchmark Botanics, you can compare the effects of market volatilities on Bionoid Pharma and Benchmark Botanics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bionoid Pharma with a short position of Benchmark Botanics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bionoid Pharma and Benchmark Botanics.

Diversification Opportunities for Bionoid Pharma and Benchmark Botanics

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Bionoid and Benchmark is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Bionoid Pharma and Benchmark Botanics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Benchmark Botanics and Bionoid Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bionoid Pharma are associated (or correlated) with Benchmark Botanics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Benchmark Botanics has no effect on the direction of Bionoid Pharma i.e., Bionoid Pharma and Benchmark Botanics go up and down completely randomly.

Pair Corralation between Bionoid Pharma and Benchmark Botanics

Given the investment horizon of 90 days Bionoid Pharma is expected to generate 1.82 times more return on investment than Benchmark Botanics. However, Bionoid Pharma is 1.82 times more volatile than Benchmark Botanics. It trades about 0.05 of its potential returns per unit of risk. Benchmark Botanics is currently generating about 0.04 per unit of risk. If you would invest  118.00  in Bionoid Pharma on August 29, 2024 and sell it today you would lose (107.00) from holding Bionoid Pharma or give up 90.68% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Bionoid Pharma  vs.  Benchmark Botanics

 Performance 
       Timeline  
Bionoid Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bionoid Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Even with conflicting performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.
Benchmark Botanics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Benchmark Botanics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable forward-looking signals, Benchmark Botanics is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders.

Bionoid Pharma and Benchmark Botanics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bionoid Pharma and Benchmark Botanics

The main advantage of trading using opposite Bionoid Pharma and Benchmark Botanics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bionoid Pharma position performs unexpectedly, Benchmark Botanics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Benchmark Botanics will offset losses from the drop in Benchmark Botanics' long position.
The idea behind Bionoid Pharma and Benchmark Botanics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Other Complementary Tools

Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals